FinanceBipartisan Bills Aim to Prevent Price Gouging for Taxpayer-funded COVID-19 Drugs
The two pieces of legislation are sponsored by Representatives Jan Schakowsky and Lloyd Doggett.
Covid-19As Problems Grow with Abbott's Fast COVID Test, FDA Standards are Under Fire
The FDA has now received a total of 106 reports of adverse events for the Abbott test.
StrategyA Senator From Arizona Emerges As A Pharma Favorite
Sen. Kyrsten Sinema has received almost $100,000 from drug companies in the current election cycle, a KHN analysis shows, one...
Covid-19Chasing the Elusive Dream of a COVID-19 Cure
Drug companies are investing billions to develop effective drugs and vaccines to help end the pandemic.
Clinical CareMask Shortage Straps Pharmacists Who Need Them To Keep Medicines Pure
A survey of hospital pharmacists found that 15% of them have already seen a "major or moderate" disruption in surgical...
FinanceHealthcare Sector Sees Credit Stress Rise, Moody's Says
The ratings agency added that the healthcare sector is more inflexible than other sectors as it relates to "social risks."
FinanceNet Drug Price Hikes Easily Outpace Rate of Inflation
Net drug prices began leveling off in 2015, but the researchers said that doesn't mean that drugs are affordable for...
StrategySandoz Will Pay $195M to Settle Price Fixing Charges
It's the seventh such settlement reached by DOJ's Antitrust Division in its ongoing probe of the generic pharmaceutical industry.
FinanceCoronavirus Could Disrupt U.S. Medical Supply Lines
For U.S. hospitals, an outbreak of the coronavirus would increase demand for services, but also increase costs.
FinanceAllergan Reduces Operating Loss by 29%, Revenues Tick Up
The Dublin-based drugmaker improved on most financial metrics during 2019.
FinanceBristol-Myers Squibb Revenues Top $26B, EPS Falls 33%
The New York-based drugmaker also saw U.S. revenues rise 42% in Q4 2019.
FinanceWorldwide Sales for Merck Nearly Reach $47B
The Kenilworth, New Jersey?based drugmaker also announced plans to spin off three segments into a new company.